Skip to main content
. 2021 Aug 23;12:710947. doi: 10.3389/fendo.2021.710947

Figure 1.

Figure 1

18F-fluoro-L-dihydroxyphenylalanine (18F-DOPA)-positron emission tomography images (MIP) of pancreas. (A) The patient with diffuse congenital hyperinsulinism: homogenic 18F-DOPA uptake in pancreatic tissue. (B) The patient with focal form of congenital hyperinsulinism: focal intense 18F-DOPA -PET accumulation in the pancreatic body and physiological 18F-DOPA uptake in the pancreatic head. (C) False positive result of 18F-fluoro-L-dihydroxyphenylalanine (18F-DOPA)-positron emission tomography. Histologically proven atypical form imitates focal form of congenital hyperinsulinism with focus of adenomatous hyperplasia in the pancreatic head (arrowhead). In this case, we have found a disagreement between imaging (focal) and pathology (atypical).